Search

Author/Creator Merchan, Jaime R

1. Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer. Issue 12 (5th December 2022)

Authors:
Miller, Richard A; Luke, Jason John; Hu, Shenshen; Mahabhashyam, Suresh; Jones, William B; Marron, Thomas; Merchan, Jaime R; Hughes, Brett G M; Willingham, Stephen B
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 12(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. Issue 6 (June 2019)

Authors:
Wilky, Breelyn A; Trucco, Matteo M; Subhawong, Ty K; Florou, Vaia; Park, Wungki; Kwon, Deukwoo; Wieder, Eric D; Kolonias, Despina; Rosenberg, Andrew E; Kerr, Darcy A; Sfakianaki, Efrosyni; Foley, Mark; Merchan, Jaime R; Komanduri, Krishna V; Trent, Jonathan C
Journal:
Lancet oncology
Issue:
Volume 20:Issue 6(2019)
Page Start:
837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study. Issue 3 (March 2023)

Authors:
Choueiri, Toni K; Eto, Masatoshi; Motzer, Robert; De Giorgi, Ugo; Buchler, Tomas; Basappa, Naveen S; Méndez-Vidal, María José; Tjulandin, Sergei; Hoon Park, Se; Melichar, Bohuslav; Hutson, Thomas; Alemany, Carlos; McGregor, Bradley; Powles, Thomas; Grünwald, Viktor; Alekseev, Boris; Rha, Sun Youn...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 3(2023)
Page Start:
228
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors. Issue 1 (20th January 2023)

Authors:
Rudin, Charles M; Pandha, Hardev S; Zibelman, Matthew; Akerley, Wallace L; Harrington, Kevin J; Day, Daphne; Hill, Andrew G; O'Day, Steven J; Clay, Timothy D; Wright, Gavin M; Jennens, Ross R; Gerber, David E; Rosenberg, Jonathan E; Ralph, Christy; Campbell, David C; Curti, Brendan D; Merchan, Ja...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗